Back to all Thought Leadership

Senate Votes ‘Yes’ to Califf as Next FDA Commissioner

February 25, 2016

On Tuesday, February 23, the US Senate confirmed Robert Califf, MD to serve as the next FDA Commissioner. The position, held by Margaret Hamburg, MD for six years until she resigned in March 2015, was temporarily held by Stephen Ostroff, MD. Dr. Ostroff served as the Acting Commissioner for the ten month duration during which the final decision was being made regarding the appointment of the next Commissioner.

The Senate did not arrive at this decision without challenges; Califf, nominated by President Obama in September of last year, has received a lot of criticism. Ultimately, the objections were overcome although not unanimously; the final vote was 89-4.

For more information about Dr. Califf’s journey, view our previous FDA News articles:
Agency Alerts



Related Articles

FDA North America

February 25, 2016

Coronavirus (COVID-19) Update: FDA Approves First COVID-19 Treatment for Young Children

April 25, 2022 Today, the U.S. Food and Drug Administration expanded the approval of the COVID-19 treatment Veklury (remdesivir) to include pediatric patients 28 days of age and older weighing at...

Read the Full Article
FDA Monograph Drug

February 25, 2016

FDA Announces OTC Monograph Drug User Fees for Fiscal Year 2022

Monday, March 14, 2022 Today, the U.S. Food and Drug Administration announced the rates for over-the-counter (OTC) monograph drug user fees for fiscal year (FY) 2022 in a Federal Register Notice...

Read the Full Article
Agency Alerts General Regulatory

February 25, 2016

Opioid Epidemic: FDA “Ups the Ante” on Labeling Requirements for Opioid Painkillers

On Tuesday, March 22 the FDA announced class-wide safety labeling changes for all immediate-release opioid painkillers. FDA stated that these changes are being made as part of the Agency’s...

Read the Full Article